Post-test: Medical Options for Transgender Youth

Question Title

* 1. Transgender youth:

Always know they are transgender from an early age

Usually tell their families as soon as they understand their identity

Often have a significant delay between recognition of gender incongruence and disclosure to family

Always continue to identify with the same gender identity after disclosure

Often confuse gender identity with sexual orientation

Question Title

* 2. Which of the following is a NOT DSM-V criteria for a diagnosis of Gender Dysphoria?

Marked incongruence between one’s experienced/expressed gender and primary &/or secondary sex characteristics

Strong desire to be rid of one’s primary &/or secondary sex characteristics

Strong desire to be of the other gender (or alt. gender)

Strong romantic &/or sexual attraction to the other gender (or some alt. gender)

Strong conviction that one has the typical feelings & reactions of the other gender (or some alt. gender)

Question Title

* 3. Which of these indicates that a youth is ready to initiate treatment with puberty blockers?

Reaching Tanner Stage 2-3

Emergence of pubic hair

Body weight at least 85 pounds

Face or body acne

Patient or family request hormonal treatment

Question Title

* 4. True or false: The causes of Gender Dysphoria are well known and very important to establish before treatment can begin.

True

False

Question Title

* 5. If divorced parents share equal custody of a gender expansive patient who is under age 18, who must give consent for the youth to begin hormone therapy?

Both parents

Either parent

One parent if the other is unknown, missing, or incarcerated

A "guardian ad litem" through the courts

Patient may give consent for self

Question Title

* 6. When a transgender child's chosen name is used appropriately, across multiple contexts, their risk for suicidal behavior is reduced by:

12%

28%

56%

78%

Question Title

* 7. Please rank these gender affirming treatments in order from least (1) to most (5) permanent.

Question Title

* 8. What is the most serious adverse risk typically associated with puberty blockers?

Deep vein thrombosis (blood clots)

Hypertension

Elevated liver enzymes

Breast cancer

Inadequate development of bone density

Question Title

* 9. How long does maximum breast tissue development take for a patient using feminizing hormone treatment?

2-3 months

6-8 months

12-18 months

2-3 years

5 or more years

Question Title

* 10. Where can you go to find ongoing education, current best practices, and updated guidelines regarding transgender care?

WPATH

The Fenway Institute

The Endocrine Society

Transline

All of the above

Question Title

* 11. A complete Post-test is required in order to earn Continuing Education credit and or a Certificate of Completion for this course, please enter your first and last name.